Opportunity

A NON-INVASIVE, DRUG-FREE, NATURAL APPROACH TO MANAGE PAIN AND ACCELERATE RECOVERY

The Problem
The world is experiencing a global health crisis involving such conditions as cardiovascular, cancers & oncology, neurological, hepatic, renal, inflammatory diseases, sleep disorders, respiratory difficulties, and injury recovery & rehabilitation.
Oxidative Stress on a cellular level affects the function of tissues and organs and eventually of the whole body, and is a commonality across these diseases and can be responsible (to varying extents) in their onset and/or progression.
Conditions relating to Oxidative Stress have an impact on the global health market conservatively of $769B USD.
The Solution
Guided by extensive anecdotal observations and over 40,000 hours of research and development spanning 10 years,  OptiRTP has developed a proprietary therapy that reduces cellular oxidative stress, assisting to amplify the body’s natural ability to recover across a multitude of conditions and injuries as well as improve overall wellness.
OptiRTP offers a globally-scalable subscription-based digital therapeutic service featuring a proprietary and dynamic modulation of infrasound frequencies.  Optimum Bio Sound Therapy (OBST) is non-invasive, drug-free and can be used in the comfort of your own home.
Strategic Global Market Penetration
OBST has been in commercial use since 2019 in over 7 countries. Since then, the Company has refined OBST in order to reduce overhead costs, improved user experience, assisted Olympic and World Champion athletes in accelerated recovery and designed data systems for mass scalability.
The Company now has a clear strategic global market penetration path utilizing identified well-defined partnerships including:

Global Sports Influencer & Affiliate Marketing

Sports Influencers and Athlete Affiliate marketing firm with over 20,000 athletes from 130 countries and 170 sports that will design, implement and manage affiliate sports marketing campaigns, as well as analytic reporting analysis.

US-Based Clinical Trial

US based University, College of Medicine, Tier 1 in Best Medical Schools, and Tier 2 in Best Medical Schools Primary Care, Clinical and Translational Science Award (CTSA) institution, a top-40 medical school for research according to U.S. News and World Report.

Proprietary OEM Components & Patent

US-based all-in-one Solution for OEMs with pre-integrated Internet of Things (IoT) cloud framework with mobile app and IoT gateway solution to build different industry solutions.

Centralized Global Support Systems for affiliates and customers

A trusted partner for customer service outsourcing, inbound call center services, and BPO solutions, empowering businesses worldwide to achieve excellence and scalability with proven support and measurable results.

Global Regulatory Registrations in targeted countries

Twenty-seven years of regulatory expertise and conducted thousands of MedTech registrations worldwide, cutting-edge regulatory affairs technology that allows you to start a device-specific registration in over 140 countries in less than a minute and have customized submission files and process management in less than five minutes.
Initial Public Offering (IPO)

A market cap valuation of $1B USD, using a conservative 10x multiplier, can be achieved by obtaining $100M USD annualized sales.

To reach an annualized revenue of $100M USD, a monthly revenue of $8.4M USD is necessary.

This equates to generating an average of 168,000 OBST subscriptions at a price point of $50 USD monthly each.

In perspective - to achieve 1%  of the identified $769B USD global health market ($7.69B USD) in annualized revenue, the Company would only need 12.82 million subscribers globally at $50 USD per month.

Interested in learning more?

Click the button below to sign required disclosures and receive more details